FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine. The nasal drug delivery directly to patient's brains is ensured by a conductor for therapeutic electrophoresis coupled with a device for the drug delivery. A controller adjusts an electrical charge fed to the conductor for therapeutic electrophoresis. The conductor for therapeutic electrophoresis can be introduced in each nasal cavity. The given conductor is preferentially enclosed in a tube used for the nasal drug delivery. A cleaning solution may be also delivered into the nasal cavity after the treatment for the purpose of relieving an irritation following therapeutic electrophoresis.
EFFECT: group of inventions enables a more safe procedure of the drug delivery with total delivery control ensured.
13 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NASAL DRUG DELIVERY DEVICE | 2012 |
|
RU2612506C2 |
| DEVICE FOR NASAL DRUG DELIVERY | 2012 |
|
RU2728583C2 |
| METHOD FOR TREATING ACCOMMODATION SPASMS | 1992 |
|
RU2048798C1 |
| METHODS, PHARMACEUTICAL COMPOSITIONS AND PRODUCTS FOR THERAPEUTIC CELL INTRODUCTION INTO ANIMAL'S CENTRAL NERVOUS SYSTEM | 2008 |
|
RU2468818C2 |
| VECTOR BASED ON ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM | 2016 |
|
RU2804953C2 |
| ADENO-ASSOCIATED VIRUS VECTOR FOR THERAPEUTIC DELIVERY INTO THE CENTRAL NERVOUS SYSTEM | 2016 |
|
RU2751952C2 |
| METHOD FOR TREATING THE CASES OF TOBACCO ADDICTION | 2004 |
|
RU2266116C1 |
| METHODS AND COMPOSITIONS FOR IMPROVED DELIVERY OF MACROMOLECULES | 2009 |
|
RU2522245C2 |
| ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO CENTRAL NERVOUS SYSTEM | 2014 |
|
RU2692251C2 |
| ADENO-ASSOCIATED VIRUS-MEDIATED GENE TRANSFER INTO THE CENTRAL NERVOUS SYSTEM | 2014 |
|
RU2801511C1 |
